EWK-21398-15311
4 vaccinations
4 coded responses
23 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 176 / PA
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-05
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2022-01-27
Survey response — 12 months, dose 2MedDRA: Gestational diabetes, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy, gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-27
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-01
-
2022-09-26
Dose 4 — Moderna
-
2022-09-30
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph node near collar boneMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: SwellingFree text: Swollen lymph node near collarboneMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph node near collarboneMedDRA releases: 2024-11 · check-in free text available
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: Pregnancy, gestational diabetes
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen lymph node near collar bone
Systemic reaction (other): Swollen lymph node near collarbone
Systemic reaction (other): Swollen lymph node near collarbone
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release